Stay updated on SHP2 Inhibitor BBP-398 Clinical Trial
Sign up to get notified when there's something new on the SHP2 Inhibitor BBP-398 Clinical Trial page.

Latest updates to the SHP2 Inhibitor BBP-398 Clinical Trial page
- Check6 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA 403 Forbidden page is now shown when loading the study record, replacing the usual content with an access-restricted notice. This indicates an access restriction rather than a change to the study data.SummaryDifference17%

- Check48 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing v3.6.5, indicating a minor update to the page template/version. This change does not affect the study details or user-facing information.SummaryDifference0.1%

- Check69 days agoChange DetectedPage revision label updated to v3.6.5, replacing the previous v3.6.4 build. This indicates a new page build of the ClinicalTrials.gov study details without changing visible content.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page shows an updated revision label, moving from v3.6.3 to v3.6.4. This indicates a recent deployment or patch to the site rather than changes to the study details.SummaryDifference0.1%

- Check105 days agoChange DetectedRevision updated from v3.6.0 to v3.6.3 on the page, indicating a newer build of the site. No visible study details or content were changed.SummaryDifference0.1%

Stay in the know with updates to SHP2 Inhibitor BBP-398 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SHP2 Inhibitor BBP-398 Clinical Trial page.